novo nordisk obesity news - Search News

Novo Nordisk, Health Canada

Reuters on MSN · 22h

Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults, the Danish drugmaker said on Wednesday.

cbc.ca on MSN · 19h

Health Canada approves Novo Nordisk's obesity drug to reduce risk of non-fatal heart attack

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults

Pharmaceutical Technology · 4h

Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks

Health Canada has approved Novo Nordisk’s semaglutide injection, Wegovy, to reduce the risk of non-fatal myocardial infarction (MI).

Global News · 1d

Wegovy approved in Canada to combat risk of non fatal-heart attack

Health Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults.

obesity, Joe Biden

Novo, Lilly shares rise as Biden proposes obesity care coverage

Shares of Danish weight-loss drug maker Novo Nordisk rose 1.3% on Tuesday as U.S. President Joe Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid.

news.bloomberglaw · 1d

Biden Proposal to Cover Obesity Drugs Sets Up Quandary for Trump

The Biden administration is proposing a rule that would require Medicare and Medicaid to cover weight-loss drugs, potentially expanding access for millions of Americans with obesity and creating a huge new medical bill for President-elect Donald Trump.

USA Today · 1d

Biden proposes Medicare, Medicaid cover pricey weight-loss drugs for obese Americans

Millions of Americans could soon have access to weight-loss medications that some have called "miracle drugs."

Wall Street Journal on MSN1d

Novo Nordisk Says White House Obesity Plan Is Step in Right Direction

Novo Nordisk is encouraged by White House proposals that could support patients using weight-loss drugs, but cautioned ...

Bloomberg L.P.3d

Novo Nordisk Foundation Targets US, Europe After Obesity Boost

The Novo Nordisk Foundation’s assets have swelled with the success of diabetes and obesity treatments Ozempic and ...

2don MSN

Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau

The results shed light on how MariTide may measure up to weight loss injections from Novo Nordisk and Eli Lilly and other ...

10d

Novo Nordisk launches obesity drug Wegovy in China

Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest ...

3d

Novo Nordisk: Can CagriSema Show 25% Weight Loss In REDEFINE-1 Trial?

Novo Nordisk will report the topline results from the REDEFINE-1 trial of CagriSema in obese patients before the end of the ...

6don MSN

Novo Nordisk’s Wegovy launches in China, offering obesity drug at a fraction of US prices

According to Reuters and CNN, Novo Nordisk announced Monday that it has launched its popular obesity drug Wegovy in China, ...

8don MSN

Is Novo Nordisk Stock a Buy Right Now?

Novo Nordisk stock has been pretty volatile lately, making it hard to judge whether now is a good opportunity to buy shares.

2don MSN

Novo Nordisk shares rise as Biden proposes obesity care coverage

COPENHAGEN (Reuters) -Shares of Danish weight-loss drug maker Novo Nordisk rose 1.3% on Tuesday as U.S. President Joe Biden ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results